In This Section


  • Clues to Heart Disease in Unexpected Places, Temple Researchers Discover

    A major factor in the advance of heart disease is the death of heart tissue, a process that a team of scientists at Temple University School of Medicine's (TUSM) Center for Translational Medicine think could be prevented with new medicines. Now, the researchers are one step closer to achieving that goal, thanks to their discovery of a key molecule in an unexpected place in heart cells – mitochondria, tiny energy factories that house the controls capable of setting off cells' self-destruct sequence.

  • Temple Establishes Institute for Population Health

    (Philadelphia, PA) – The Temple University Health System (TUHS) has established an Institute for Population Health, which will further solidify Temple’s commitment to developing innovative programs to enhance the health of individuals and populations, while increasing healthcare quality and lowering its cost.

  • Temple University School of Medicine Ranked as One of the Nation's Top Medical Schools by U.S. News & World Report

    Temple University School of Medicine (TUSM) is once again listed as one of the top research-oriented medical schools in the nation in U.S. News & World Report’s Best Medical Schools 2014 rankings. Temple had the second-highest ranking of all medical schools in Philadelphia.

    TUSM earned its ranking by exhibiting excellence in a number of measures including student admission selectivity, research activity, and its reputation among peer institutions and residency directors.

  • Temple Researchers Discover Key to Heart Failure, New Therapies on Horizon

    Some 5.8 million Americans suffer from heart failure, a currently incurable disease. But scientists at Temple University School of Medicine’s (TUSM) Center for Translational Medicine have discovered a key biochemical step underlying the condition that could aid the development of new drugs to treat and possibly prevent it.

  • Temple Scientists Find Cervical Cancer-Causing Virus In The Brain, Show Potential Connection To Epilepsy

    Researchers at Shriners Hospitals Pediatric Research Center at the Temple University School of Medicine and the University of Pennsylvania have evidence linking the human papillomavirus 16 (HPV16) – the most common cause of cervical cancer – to a common form of childhood epilepsy.

  • Temple Researchers Testing Miniature Lung Coils as a Novel Treatment For Emphysema

    Temple researchers are testing whether implanting miniature coils in the airways of diseased lungs can improve breathing, activity levels and quality of life for emphysema patients.

    The coils work by compressing damaged tissue, which allows the healthier parts of the lung to function more efficiently and make breathing easier. The coils are made of Nitinol, a metal commonly used in medical implants, and offer a minimally invasive alternative to lung volume reduction surgery.

  • Temple Scientist Awarded Grants for Lung, Brain Injury Studies

    A researcher at Temple University School of Medicine has been awarded a pair of grants totaling nearly $4.5 million from the Office of Naval Research (ONR) to study the use and effectiveness of a type of chemical in helping protect the lungs of soldiers and other military personnel from the effects of high altitude. In a separate project, she plans to examine the chemical’s usefulness in lessening the impact of traumatic brain injuries.

  • Temple Researchers Receive $11.6 Million to Study Ways to Reduce Heart Attack Damage

    Scientists at Temple University School of Medicine have been awarded a five-year, $11.6 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to develop new approaches to prevent, slow or reverse damage to the heart after a heart attack.